(TAYD) Taylor Devices - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US8771631053
Stock: Seismic Dampers, Shock Absorbers, Vibration Dampers, Fluidicshoks, Crane Buffers
Total Rating 62
Risk 96
Buy Signal 1.58
| Risk 5d forecast | |
|---|---|
| Volatility | 54.3% |
| Relative Tail Risk | -12.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.95 |
| Alpha | 135.49 |
| Character TTM | |
|---|---|
| Beta | 0.666 |
| Beta Downside | 0.462 |
| Drawdowns 3y | |
|---|---|
| Max DD | 52.65% |
| CAGR/Max DD | 1.34 |
EPS (Earnings per Share)
Revenue
Description: TAYD Taylor Devices January 08, 2026
Taylor Devices, Inc. (NASDAQ:TAYD) designs and manufactures a portfolio of shock-absorption and energy-storage solutions-including seismic dampers, Fluidicshoks, industrial buffers, self-adjusting shock absorbers, liquid die springs, vibration dampers, machined springs, and custom isolators/actuators-serving aerospace, defense, heavy-industry, and infrastructure markets worldwide from its North Tonawanda, NY headquarters.
In FY 2023 the company reported roughly $115 million in revenue, up about 8 % year-over-year, driven by heightened demand for seismic protection in infrastructure projects and rising defense spending that fuels aerospace vibration-control orders. The global vibration-control market is projected to grow at a 6 % CAGR through 2028, while U.S. infrastructure resilience spending is expected to exceed $200 billion over the next five years, both of which underpin Taylor Devices’ growth outlook.
For a deeper quantitative view, consider checking ValueRay’s analyst tools to explore the company’s valuation metrics and peer comparisons.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 9.89m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.19 > 0.02 and ΔFCF/TA 18.53 > 1.0 |
| NWC/Revenue: 109.4% < 20% (prev 104.2%; Δ 5.19% < -1%) |
| CFO/TA 0.24 > 3% & CFO 17.2m > Net Income 9.89m |
| Net Debt (-1.96m) to EBITDA (13.3m): -0.15 < 3 |
| Current Ratio: 10.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (3.15m) vs 12m ago 1.33% < -2% |
| Gross Margin: 46.14% > 18% (prev 0.41%; Δ 4573 % > 0.5%) |
| Asset Turnover: 70.22% > 50% (prev 63.35%; Δ 6.87% > 0%) |
| Interest Coverage Ratio: -35.18 > 6 (EBITDA TTM 13.3m / Interest Expense TTM -325.6k) |
Altman Z'' 10.00
| A: 0.72 (Total Current Assets 57.9m - Total Current Liabilities 5.78m) / Total Assets 72.8m |
| B: 0.89 (Retained Earnings 64.7m / Total Assets 72.8m) |
| C: 0.17 (EBIT TTM 11.5m / Avg Total Assets 67.9m) |
| D: 11.21 (Book Value of Equity 64.8m / Total Liabilities 5.78m) |
| Altman-Z'' Score: 20.50 = AAA |
Beneish M -3.65
| DSRI: 0.56 (Receivables 7.61m/11.3m, Revenue 47.6m/39.8m) |
| GMI: 0.89 (GM 46.14% / 41.11%) |
| AQI: 0.66 (AQ_t 0.03 / AQ_t-1 0.05) |
| SGI: 1.20 (Revenue 47.6m / 39.8m) |
| TATA: -0.10 (NI 9.89m - CFO 17.2m) / TA 72.8m) |
| Beneish M-Score: -3.65 (Cap -4..+1) = AAA |
What is the price of TAYD shares?
As of February 12, 2026, the stock is trading at USD 81.87 with a total of 42,724 shares traded.
Over the past week, the price has changed by +4.72%, over one month by +18.82%, over three months by +63.58% and over the past year by +146.67%.
Over the past week, the price has changed by +4.72%, over one month by +18.82%, over three months by +63.58% and over the past year by +146.67%.
Is TAYD a buy, sell or hold?
Taylor Devices has received a consensus analysts rating of 5.00.
Therefore, it is recommended to buy TAYD.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the TAYD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 48 | -41.4% |
| Analysts Target Price | 48 | -41.4% |
| ValueRay Target Price | 129 | 57.5% |
TAYD Fundamental Data Overview February 10, 2026
P/E Trailing = 16.5882
P/S = 5.3007
P/B = 3.7662
Revenue TTM = 47.6m USD
EBIT TTM = 11.5m USD
EBITDA TTM = 13.3m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -1.96m USD (from netDebt column, last quarter)
Enterprise Value = 101.3m USD (142.0m + (null Debt) - CCE 40.7m)
Interest Coverage Ratio = -35.18 (Ebit TTM 11.5m / Interest Expense TTM -325.6k)
EV/FCF = 7.20x (Enterprise Value 101.3m / FCF TTM 14.1m)
FCF Yield = 13.89% (FCF TTM 14.1m / Enterprise Value 101.3m)
FCF Margin = 29.52% (FCF TTM 14.1m / Revenue TTM 47.6m)
Net Margin = 20.75% (Net Income TTM 9.89m / Revenue TTM 47.6m)
Gross Margin = 46.14% ((Revenue TTM 47.6m - Cost of Revenue TTM 25.7m) / Revenue TTM)
Gross Margin QoQ = 47.05% (prev 44.75%)
Tobins Q-Ratio = 1.39 (Enterprise Value 101.3m / Total Assets 72.8m)
Interest Expense / Debt = unknown (Interest Expense 433.0k / Debt none)
Taxrate = 24.31% (645.0k / 2.65m)
NOPAT = 8.67m (EBIT 11.5m * (1 - 24.31%))
Current Ratio = 10.02 (Total Current Assets 57.9m / Total Current Liabilities 5.78m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = -0.15 (Net Debt -1.96m / EBITDA 13.3m)
Debt / FCF = -0.14 (Net Debt -1.96m / FCF TTM 14.1m)
Total Stockholder Equity = 62.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 14.57% (Net Income 9.89m / Total Assets 72.8m)
RoE = 15.75% (Net Income TTM 9.89m / Total Stockholder Equity 62.8m)
RoCE = 17.08% (EBIT 11.5m / Capital Employed (Total Assets 72.8m - Current Liab 5.78m))
RoIC = 13.81% (NOPAT 8.67m / Invested Capital 62.8m)
WACC = 8.37% (E(142.0m)/V(142.0m) * Re(8.37%) + (debt-free company))
Discount Rate = 8.37% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.38%
[DCF Debug] Terminal Value 80.07% ; FCFF base≈8.64m ; Y1≈10.7m ; Y5≈18.1m
Fair Price DCF = 91.22 (EV 285.2m - Net Debt -1.96m = Equity 287.1m / Shares 3.15m; r=8.37% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 66.41 | EPS CAGR: 98.39% | SUE: N/A | # QB: 0
Revenue Correlation: 16.98 | Revenue CAGR: 18.48% | SUE: N/A | # QB: 0
EPS current Year (2026-05-31): EPS=2.81 | Chg30d=+0.360 | Revisions Net=+1 | Growth EPS=-2.1% | Growth Revenue=+15.6%
EPS next Year (2027-05-31): EPS=2.87 | Chg30d=+0.180 | Revisions Net=+1 | Growth EPS=+2.1% | Growth Revenue=+6.4%
P/S = 5.3007
P/B = 3.7662
Revenue TTM = 47.6m USD
EBIT TTM = 11.5m USD
EBITDA TTM = 13.3m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -1.96m USD (from netDebt column, last quarter)
Enterprise Value = 101.3m USD (142.0m + (null Debt) - CCE 40.7m)
Interest Coverage Ratio = -35.18 (Ebit TTM 11.5m / Interest Expense TTM -325.6k)
EV/FCF = 7.20x (Enterprise Value 101.3m / FCF TTM 14.1m)
FCF Yield = 13.89% (FCF TTM 14.1m / Enterprise Value 101.3m)
FCF Margin = 29.52% (FCF TTM 14.1m / Revenue TTM 47.6m)
Net Margin = 20.75% (Net Income TTM 9.89m / Revenue TTM 47.6m)
Gross Margin = 46.14% ((Revenue TTM 47.6m - Cost of Revenue TTM 25.7m) / Revenue TTM)
Gross Margin QoQ = 47.05% (prev 44.75%)
Tobins Q-Ratio = 1.39 (Enterprise Value 101.3m / Total Assets 72.8m)
Interest Expense / Debt = unknown (Interest Expense 433.0k / Debt none)
Taxrate = 24.31% (645.0k / 2.65m)
NOPAT = 8.67m (EBIT 11.5m * (1 - 24.31%))
Current Ratio = 10.02 (Total Current Assets 57.9m / Total Current Liabilities 5.78m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = -0.15 (Net Debt -1.96m / EBITDA 13.3m)
Debt / FCF = -0.14 (Net Debt -1.96m / FCF TTM 14.1m)
Total Stockholder Equity = 62.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 14.57% (Net Income 9.89m / Total Assets 72.8m)
RoE = 15.75% (Net Income TTM 9.89m / Total Stockholder Equity 62.8m)
RoCE = 17.08% (EBIT 11.5m / Capital Employed (Total Assets 72.8m - Current Liab 5.78m))
RoIC = 13.81% (NOPAT 8.67m / Invested Capital 62.8m)
WACC = 8.37% (E(142.0m)/V(142.0m) * Re(8.37%) + (debt-free company))
Discount Rate = 8.37% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.38%
[DCF Debug] Terminal Value 80.07% ; FCFF base≈8.64m ; Y1≈10.7m ; Y5≈18.1m
Fair Price DCF = 91.22 (EV 285.2m - Net Debt -1.96m = Equity 287.1m / Shares 3.15m; r=8.37% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 66.41 | EPS CAGR: 98.39% | SUE: N/A | # QB: 0
Revenue Correlation: 16.98 | Revenue CAGR: 18.48% | SUE: N/A | # QB: 0
EPS current Year (2026-05-31): EPS=2.81 | Chg30d=+0.360 | Revisions Net=+1 | Growth EPS=-2.1% | Growth Revenue=+15.6%
EPS next Year (2027-05-31): EPS=2.87 | Chg30d=+0.180 | Revisions Net=+1 | Growth EPS=+2.1% | Growth Revenue=+6.4%